Enanta Pharmaceuticals (ENTA) Net Cash Flow Growth (1y) (2013 - 2026)
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | NCF Growth (1y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Quantum Biopharma | 961,148.99 Bn | 961,148.98 Bn | - | 198.34% |
| 2 | Alterity Therapeutics | 744,933.29 Bn | 744,933.26 Bn | - | - |
| 3 | Legend Biotech | 2,540.00 Bn | 2,539.71 Bn | 242.10 Mn | 467.41% |
| 4 | Nanobiotix | 2,199.85 Bn | 2,199.78 Bn | - | - |
| 5 | Akari Therapeutics | 1,635.88 Bn | 1,635.88 Bn | - | -14,223.53% |
| 6 | Vertex Pharmaceuticals | 111.32 Bn | 104.07 Bn | 2.59 Bn | 453.08% |
| 7 | Evaxion A | 62.56 Bn | 62.54 Bn | - | - |
| 8 | Regeneron Pharmaceuticals | 62.55 Bn | 53.79 Bn | 3.31 Bn | -125.22% |
| 9 | Alnylam Pharmaceuticals | 39.57 Bn | 36.56 Bn | 959.66 Mn | 53.46% |
| 10 | Enanta Pharmaceuticals | 367.22 Mn | 203.44 Mn | - | 89.86% |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 89.86% |
| Dec 31, 2025 | -89.09% |
| Sep 30, 2025 | -958.30% |
| Jun 30, 2025 | 44.53% |
| Mar 31, 2025 | -204.81% |
| Dec 31, 2024 | 203.65% |
| Sep 30, 2024 | 114.89% |
| Jun 30, 2024 | -226.22% |
| Mar 31, 2024 | -23.73% |
| Dec 31, 2023 | -2,466.63% |
| Sep 30, 2023 | -162.64% |
| Jun 30, 2023 | 337.52% |
| Mar 31, 2023 | 153.30% |
| Dec 31, 2022 | -104.23% |
| Sep 30, 2022 | -70.29% |
| Jun 30, 2022 | 87.23% |
| Mar 31, 2022 | -363.62% |
| Dec 31, 2021 | 230.67% |
| Sep 30, 2021 | 513.43% |
| Jun 30, 2021 | -384.22% |
| Mar 31, 2021 | -52.91% |
| Dec 31, 2020 | -35.33% |
| Sep 30, 2020 | 70.39% |
| Jun 30, 2020 | 315.81% |
| Mar 31, 2020 | 47.73% |
| Dec 31, 2019 | -326.24% |
| Sep 30, 2019 | -300.59% |
| Jun 30, 2019 | 51.64% |
| Mar 31, 2019 | 2,909.67% |
| Dec 31, 2018 | 339.99% |
| Sep 30, 2018 | -50.65% |
| Jun 30, 2018 | -901.08% |
| Mar 31, 2018 | 19.90% |
| Dec 31, 2017 | -41.15% |
| Sep 30, 2017 | 628.64% |
| Jun 30, 2017 | 109.67% |
| Mar 31, 2017 | -113.89% |
| Dec 31, 2016 | -83.51% |
| Sep 30, 2016 | -536.34% |
| Jun 30, 2016 | -434.47% |
| Mar 31, 2016 | 220.86% |
| Dec 31, 2015 | 614.28% |
| Sep 30, 2015 | -56.49% |
| Jun 30, 2015 | -171.40% |
| Mar 31, 2015 | -161.27% |
| Dec 31, 2014 | 177.40% |
| Sep 30, 2014 | 143.17% |
| Jun 30, 2014 | 114.88% |
| Mar 31, 2014 | -74.55% |
| Dec 31, 2013 | -143.36% |
| Sep 30, 2013 | -252.96% |
| Jun 30, 2013 | -232.04% |